clinical trials

Icon’s June 22, 2026 Microsoft partnership puts Copilot, enterprise cloud, data infrastructure, and the Orbis agentic AI platform into the operating fabric of clinical trials run by the Dublin-based CRO, leaving sponsors and sites to determine who absorbs the change-management burden. The...

Samsung announced on June 24, 2026, that it is partnering with clinical research organization Alcedis to use biometric data from consenting Galaxy Watch users in medical research and drug-development studies, aiming to turn smartwatch signals into evidence usable by pharmaceutical companies and...

ICON’s June 22, 2026 decision to name Microsoft as a preferred technology partner gives the Dublin-based clinical research organization a Microsoft-backed foundation for scaling Orbis, its governed agentic AI platform, across clinical trial design, operations, documentation, monitoring, and...

ICON plc announced on June 22, 2026, in Dublin that it has selected Microsoft as a preferred technology partner for a three-year digital innovation and AI investment plan spanning Microsoft 365 Copilot, Fabric, Azure data services, and clinical-trial AI infrastructure. The deal matters less as...

Pharmaceutical companies are reporting that artificial intelligence is already cutting measurable time from clinical trials and the heavy paperwork that surrounds regulatory submissions — not by inventing new drugs overnight, but by streamlining the “messy middle” of development: site selection...

The accelerating integration of artificial intelligence (AI) in biomedical research is ushering in a profound transformation—one that not only speeds up the discovery of new treatments but also redefines the scientific process, the structure of clinical trials, and the very nature of how we view...

In the rapidly shifting landscape of oncological care, clinicians, researchers, and technologists are grappling with a daunting reality: every year, roughly 20 million people receive a cancer diagnosis worldwide. Each patient, distinct in biology and medical history, triggers a cascade of...

The first human trial of an experimental vaccine against Ebola suggests that it is safe and may help the immune system to combat the virus. Twenty volunteers were immunised in the United States. Scientists at the US National Institutes of Health (NIH) described the results as "promising". The...

Scientists at the University of Texas are developing the breathable vaccine It has been shown to protect monkeys against the deadly virus Next step is to test vaccine on humans in phase one clinical trials Researchers said respiratory vaccine could overcome logistical problems of storing...

Procedure could be permanent cure ! A radical therapy that zaps the kidneys with radio waves could provide a permanent cure for high blood pressure, research shows. The procedure may be available on the NHS as early as next year after trials showed it produced dramatic improvements in the...

Most of us get a little excited when we see a big spider, but for the unfortunate few who fall victim to the bite of the daunting Brazilian wandering spider, that “excitement” takes on a whole new meaning: The venom of the wandering spider -- also known as the banana spider (or more formally...